Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kimihiro Shimizu"'
Autor:
Masahiro Tsuboi, Tomohiro Murakawa, Morihito Okada, Masayuki Chida, Kenji Suzuki, Kenichi Yoshimura, Yoichi Ohtaki, Tetsuya Mitsudomi, Hiroyuki Suzuki, Motoshi Takao, Hiroyuki Ito, Kimihiro Shimizu
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 153
Objectives The prognostic impact of surgical intervention for recurrent or residual non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutation or anaplastic lymphoma kinase (ALK) rearrangement after tyrosine-kinase
Autor:
Tadashi Handa, Yasuhiko Koga, Kimihiro Shimizu, Tetsunari Oyama, Hiroaki Masubuchi, Kyoichi Kaira, Takehiko Yokobori, Koichi Yamaguchi, Reiko Sakurai, Kenichiro Hara, Norimitsu Kasahara, Takeshi Hisada, Takayuki Asao, Tetsuya Higuchi, Hiroaki Tsurumaki
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 134
Objectives Positron emission tomography (PET) using 2-deoxy-2-[18F] fluoro-D-glucose (18F-FDG) is a clinically useful modality for cancer evaluation. The mechanism of 18F-FDG uptake within cancer cells involves the glucose transporter 1 (GLUT1) and h
Autor:
Hiroyuki Kuwano, Yoichi Ohtaki, Bilguun Erkhem-Ochir, Pinjie Bao, Norimitsu Kasahara, Kyoichi Kaira, Takehiko Yokobori, Yukiko Arisaka, Takayuki Asao, Toshiki Yajima, Tetsuya Higuchi, Akira Mogi, Yoshito Tsushima, Noriaki Sunaga, Kimihiro Shimizu, Tetsunari Oyama, Takayuki Kosaka, Masahiko Nishiyama
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 119
Objectives 2-Deoxy-2-[fluorine-18] fluoro- d -glucose with positron emission tomography (18F-FDG-PET) is a clinically useful tool for cancer evaluation. 18F-FDG accumulation in tumor cells is known to be correlated with the presence of glucose transp
Autor:
Hisao Imai, Ryusei Saito, Yasuki Iwasaki, Kimihiro Shimizu, Yoshio Tomizawa, Tamotsu Ishizuka, Noriaki Sunaga, Noriko Yanagitani, Kyoichi Kaira, Mitsuyoshi Utsugi, Hiroaki Tsurumaki, Hironobu Iijima, Masatomo Mori, Takeshi Hisada
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 68(2)
We conducted a phase II study of S-1 and carboplatin combination regimen in the treatment of patients with advanced non-small cell lung cancer (NSCLC). Chemotherapy-naive patients with advanced NSCLC were treated with S-1 and carboplatin. S-1 was adm
Autor:
Kimihiro Shimizu, Kunio Dobashi, Tamotsu Ishizuka, Yoshio Tomizawa, Ryusei Saito, Tatsuo Suga, Shigebumi Tanaka, Hironobu Iijima, Takeshi Hisada, Masatomo Mori, Kyoichi Kaira, Noriko Yanagitani, Noriaki Sunaga
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 56(3)
Summary Purpose Mutations in the epidermal growth factor receptor ( EGFR ) gene are associated with increased sensitivity of non-small cell lung cancer (NSCLC) to gefitinib, an EGFR tyrosine kinase inhibitor. The objective of this study was to prospe